You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 7, July 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas

Jennifer A. Anderson, MD; Jonathan C. Irish, MD, MS, FRCSC; C. Margaret McLachlin, MD, FRCPC; Bo Y. Ngan, MD, PhD, FRCPC

Arch Otolaryngol Head Neck Surg. 1994;120(7):755-760.


Abstract

Objective
Previous in vitro studies have demonstrated that transfection of an activated ras gene induces malignant transformation in epithelial cell lines infected with the human papillomavirus (HPV). The results of these studies support the hypothesis that HPV may co-operate with an activated ras gene in epithelial tumor carcinogenesis. To test this hypothesis in head and neck cancers, we screened 35 oral carcinomas for the presence of HPV DNA and for a mutated H-ras gene.

Design
The design of the study was a screening survey type. Twenty-seven oral squamous cell carcinomas and eight verrucous carcinomas were analyzed for the presence of HPV DNA using the polymerase chain reaction, followed by Southern blot and probe hybridization. The tumors were also screened for point mutations of the H-ras gene using the polymerase chain reaction and restriction fragment length polymorphism analysis.

Results
Six (22%) of the 27 oral squamous cell carcinomas demonstrated point mutation in the H-ras gene. In addition, six tumors (22%) were positive for HPV DNA, with three tumors (11%) demonstrating both HPV DNA and H-ras gene point mutation. While the rate of simultaneous HPV infection and ras gene activation by point mutation was 11% in oral squamous cell carcinomas, 25% of oral verrucous carcinomas contained both HPV DNA and mutation in the H-ras gene.

Conclusions
These results suggest a stronger association between HPV infection and activation of the H-ras gene in oral verrucous carcinomas. These results continue to confirm the multihit hypothesis of tumorigenesis and suggest that in some cases of oral cancer at least two of these events are H-ras gene mutation and HPV infection.

(Arch Otolaryngol Head Neck Surg. 1994;120:755-760)



Author Affiliations

From the Departments of Otolaryngology (Drs Anderson and Irish) and Pathology (Drs McLachlin and Ngan), University of Toronto (Ontario); the Head and Neck Program, The Toronto Hospital, and Conacher Head and Neck Cancer Research Laboratory (Dr Irish); and the Department of Pathology, Sunnybrook Health Science Centre (Dr Ngan), Toronto.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Raimondi et al.
Cancer Res. 2009;69:4159-4166.
ABSTRACT | FULL TEXT  

Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy
Choi and Myers
JDR 2008;87:14-32.
ABSTRACT | FULL TEXT  

Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma.
Lu et al.
Genes Dev. 2006;20:1331-1342.
ABSTRACT | FULL TEXT  

Inducible Activation of Oncogenic K-ras Results in Tumor Formation in the Oral Cavity
Caulin et al.
Cancer Res. 2004;64:5054-5058.
ABSTRACT | FULL TEXT  

Advances in Chemoprevention of Head and Neck Cancer
Rhee et al.
The Oncologist 2004;9:302-311.
ABSTRACT | FULL TEXT  

Deregulated Cyclooxygenase-2 Expression in Oral Premalignant Tissues
Banerjee et al.
Molecular Cancer Therapeutics 2002;1:1265-1271.
ABSTRACT | FULL TEXT  

Conversion of Normal To Malignant Phenotype: Telomere Shortening, Telomerase Activation, and Genomic Instability During Immortalization of Human Oral Keratinocytes
Kang and Park
CROBM 2001;12:38-54.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.